NBIONascent BiotechNBIO info
$0.05info-0.86%24h
Global rank30729
Market cap$8.42M
Change 7d-17.21%
YTD Performance-71.94%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Nascent Biotech (NBIO) Stock Overview

    Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. The company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. In addition, it develops CLNH5. Nascent Biotech, Inc. is based in North Palm Beach, Florida.

    NBIO Stock Information

    Symbol
    NBIO
    Address
    631 US Hwy 1North Palm Beach, FL 33408United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.nascentbiotech.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    612 961 5656

    Nascent Biotech (NBIO) Price Chart

    -
    Value:-

    Nascent Biotech Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.050500002
    N/A
    Market Cap
    $8.42M
    N/A
    Shares Outstanding
    166.74M
    N/A
    Employees
    0
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org